Evaluation of Novel Biomarkers in Early Recognition of Acute Kidney Injury After Orthopedic Operations.
1 other identifier
observational
200
1 country
2
Brief Summary
Surgical treatment of hip fracture may be complicated by acute kidney injury. The aim of this study is to investigate whether the investigators can find a better biomarker than creatinine to recognize this problem at an earlier stage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2022
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 21, 2022
CompletedStudy Start
First participant enrolled
March 15, 2022
CompletedFirst Posted
Study publicly available on registry
March 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2023
CompletedApril 5, 2022
April 1, 2022
1.6 years
January 21, 2022
April 4, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Any stage of acute kidney injury as defined by Kidney Diseases Improving Global Outcome
Concentration of novel biomarkers, its change and change of renal resistive index considering different stages of acute kidney injury
120 hours
Secondary Outcomes (3)
Kidney perfusion evaluated by Renal Resistive Index (RRI)
48 hours
Analysis of proenkephalin concentration
24 hours
Kidney dysfunction and mortality
30 days
Interventions
blood and urine sampling before and after surgery (1-admission to operating ward, 2-leaving operation ward, 1st day postop, 2nd day postop, 5th day postop, or the day patient leaves hospital, whichever is first)
patients able to cooperate will have renal resistive index measured before and after surgery (admission to operating ward, leaving operating ward)
Eligibility Criteria
all patients able to provide informed consent, who do not have diagnosed end stage renal disease undergoing surgical treatment of hip fracture (either joint alloplasty or internal fixation)
You may qualify if:
- age at least 18 years
- be able to provide informed consent
You may not qualify if:
- end stage renal disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Gruca Orthopaedic and Trauma Teaching Hospital
Otwock, Masovian Voivodeship, 05-400, Poland
I Department of Anesthesiology and Intensive Care Warsaw Medical University
Warsaw, Masovian Voivodeship, 02-005, Poland
Biospecimen
urine and plasma from centrifuged whole blood after partial analysis of biomarkers
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 21, 2022
First Posted
March 18, 2022
Study Start
March 15, 2022
Primary Completion
November 1, 2023
Study Completion
November 1, 2023
Last Updated
April 5, 2022
Record last verified: 2022-04